
This study examines how the development of cardiovascular and renal disease (CVRD) translates to hospital healthcare costs in individuals with type 2 diabetes (T2D) initially free from CVRD. Data were obtained from the digital healthcare systems of 12 nations using a prespecified protocol. In total, 1.2 million CVRD‐free individuals with T2D were identified and followed for 4.5 years (mean), 4.9 million patient years. The proportion of individuals indexed before 2010 was 18% and after 2015, 52%. Across all nations, HF or CKD was the most frequent CVRD manifestation to develop in a low‐risk population with T2D, accounting for the highest proportion of hospital healthcare costs. These novel findings highlight the importance of cardiorenal awareness when planning healthcare.
Like
Save
Share